Filing Details
- Accession Number:
- 0001140361-10-019226
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-05 13:00:00
- Reporting Period:
- 2010-05-03
- Filing Date:
- 2010-05-05
- Accepted Time:
- 2010-05-05 18:03:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
350907 | Thoratec Corp | THOR | Electromedical & Electrotherapeutic Apparatus (3845) | 942340464 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1218700 | Lawrence Cohen | 6035 Stoneridge Drive Pleasanton CA 94588 | Division President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-05-03 | 68,651 | $15.75 | 100,980 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-05-03 | 66,000 | $41.85 | 34,980 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-05-03 | 2,651 | $42.93 | 32,329 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-05-03 | 68,651 | $0.00 | 68,651 | $15.75 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2003-02-11 | 2012-02-11 | No | 4 | M | Direct |
Footnotes
- Options and restricted stock units were granted pursuant to the Company's equity incentive plan with no payments received for either.
- Shares vest in four equal installments commencing one year after the grant date.
- This transaction was executed in multiple trades in prices ranging from $41.27 to $42.24. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades in prices ranging from $42.72 to $43.15. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.